Business Wire

CA-NETAPP,-INC.

Share
NetApp Delivers an Innovative, No-Compromise, Unified Hybrid Cloud Experience

NetApp® (NASDAQ: NTAP) a global, cloud-led, data-centric software company, today unveiled a new release of its ONTAP software that powers data services on premises and in the cloud, as well as an array of portfolio updates that leverage ONTAP to provide a flexible foundation for hybrid cloud, unify data management across on-premises and cloud environments, and simplify consumption and operation of hybrid cloud services. As the only provider of hybrid cloud solutions that offers native integration with the world’s leading public clouds, NetApp is unifying management of on-premises and public cloud environments, delivering new ways to consume and operate data services that make it easier for enterprises to put their data to work – wherever and whenever they need it.

The latest enhancements to NetApp’s hybrid cloud portfolio and ONTAP data services include:

  • Flexible Foundations for Hybrid Cloud
    Enterprises need to modernize their IT environments to enable hybrid cloud operations. NetApp is updating its foundational solutions to better support them:

    • FlexPod: The next generation of the globally trusted converged infrastructure platform from NetApp and Cisco provides a better foundation for hybrid cloud with the flexibility to run and manage all your modern workloads. New capabilities include intelligent application placement across on-premises and cloud, automated hybrid cloud data workflows, and the ability to consume FlexPod as a fully managed, cloud-like service.

    • NetApp StorageGRID: The 11.5 release of NetApp’s highly scalable object store now supports data encryption using external key management, offers compliance and ransomware protection with S3 object locks, and delivers increased performance with intelligent load balancing.
  • Simple, Unified Data Management Across Hybrid Cloud Environments
    Managing data and applications in hybrid cloud environments can be extremely challenging – enterprises need a simple, standardized approach. NetApp centralizes data management across the hybrid cloud to make things simpler. NetApp Cloud Manager and enhanced multicloud management services automate ONTAP data services to simplify application migration, disaster recovery, data protection, governance and compliance. In addition, NetApp Astra, an application-aware data service for Kubernetes, enables customers to manage, protect, and migrate stateful applications in Google Cloud, Microsoft Azure – and now on-premises.
  • Cloud-Like Financial Flexibility and Operational Simplicity
    Organizations want the same financial and operational elasticity they get from the cloud in their data center, with the freedom to move and manage workloads easily and securely across hybrid and public cloud environments. The new NetApp Keystone Flex Subscription at Equinix gives customers the ability to deploy Keystone data services in Equinix International Business Exchange™ (IBX®) for low-latency access to multiple clouds – without having to move their data to the cloud. The Keystone Flex Subscription at Equinix is uniquely delivered as a single subscription by NetApp.

“NetApp’s Keystone Flex Subscription at Equinix uniquely provides a flexible, on-demand storage alternative to traditional capex infrastructure investments,” said Royce Thomas, senior vice president, strategic alliances and global account management at Equinix. “With this offering, global businesses can host their data adjacent to the cloud and utilize Equinix Fabric™ to connect to service providers, taking advantage of centralized hybrid cloud data management across all major public clouds.”

“A hybrid cloud strategy is critical to ensuring organizations can keep pace with the growth and complexity of distributed data and applications, thrive in the face of uncertainty and compete effectively in the digital economy,” said Kim Stevenson, senior vice president and general manager, foundational data services business unit at NetApp. “NetApp specializes in helping enterprises at every phase in their digital transformation journeys to implement hybrid cloud strategies and technologies that will help keep them ahead of the curve.”

Additional Resources

About NetApp

NetApp is a global, cloud-led, data-centric software company that empowers organizations to lead with data in the age of accelerated digital transformation. The company provides systems, software and cloud services that enable them to run their applications optimally from data center to cloud, whether they are developing in the cloud, moving to the cloud, or creating their own cloud-like experiences on premises. With solutions that perform across diverse environments, NetApp helps organizations build their own data fabric and securely deliver the right data, services and applications to the right people—anytime, anywhere. Learn more at www.netapp.com or follow us on Twitter , LinkedIn , Facebook , and Instagram .

NETAPP, the NETAPP logo, and the marks listed at www.netapp.com/TM are trademarks of NetApp, Inc.

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Takeda’s Zasocitinib Landmark Phase 3 Plaque Psoriasis Data Show Promise to Deliver Clear Skin in a Once-Daily Pill, Catalyzing a New Era of Treatment18.12.2025 09:00:00 CET | Press release

Pivotal Phase 3 studies of once-daily oral zasocitinib met all primary and ranked secondary endpoints in patients with moderate-to-severe plaque psoriasis More than half of study participants treated with zasocitinib achieved clear or almost clear skin (PASI 90), and on average about 30 percent achieved completely clear skin (PASI 100) by week 16 Zasocitinib was generally well-tolerated with a safety profile consistent with previous clinical studies Takeda(TSE:4502/NYSE:TAK)today announced positive topline results for the two pivotal Phase 3randomized, multicenter, double-blind, placebo- and active comparator-controlled studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO). The studies demonstrated superiority of zasocitinib compared to placebo for the co-primary endpoints, static Physician Global Assessment (sPGA) 0/1 and Psoriasis Area and Severity Index (PASI) 75, at wee

DATROWAY® Type II Variation Application Validated in the EU as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who are Not Candidates for Immunotherapy18.12.2025 08:30:00 CET | Press release

Based on TROPION-Breast02 phase 3 trial results where Daiichi Sankyo and AstraZeneca’s DATROWAY is the first and only medicine to significantly improve overall survival versus chemotherapy in this patient population If approved, DATROWAY could become the standard of care in this setting The European Medicines Agency (EMA) has validated the Type II Variation marketing authorization application for DATROWAY® (datopotamab deruxtecan) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. DATROWAY is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/Nasdaq: AZN). The validation confirms the completion of the application and commences the scientific review process by the EMA’s Committee for Medicinal Produc

Celltrion receives positive CHMP Opinion for SteQeyma™ (ustekinumab biosimilar) autoinjector18.12.2025 03:41:00 CET | Press release

SteQeyma™45mg and 90mg solution for injection via autoinjector (pre-filled pen) receives positive CHMP opinion, which will facilitate subcutaneous administration in patients with plaque psoriasis, psoriatic arthritis (PsA) and Crohn’s disease (CD)1The new autoinjector option increases convenience, enhances individual patient experience and expands administration options Celltrion, Inc. today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion of autoinjector of SteQeyma™, a biosimilar to Stelara® (ustekinumab), for the treatment of plaque psoriasis, psoriatic arthritis (PsA) and Crohn’s disease (CD). The positive CHMP opinion is for SteQeyma autoinjector in 45mg/0.5mL and 90mg/1mL, expanding the currently approved SteQeyma™ presentation, which includes 45mg/0.5mL, 90mg/1mL in a pre-filled syringe and 45mg/0.5mL in a vial for subcutaneous injection, as well as 130mg/26mL concentrate for solution f

Megaport Expands into India, Accelerating Global Growth with Extreme IX Acquisition18.12.2025 02:15:00 CET | Press release

Through the Extreme Exchange (IX) acquisition, Megaport gains seven Internet Exchanges and access to 40+ data centres across India’s fastest-growing digital hubs. Megaport Limited (ASX: MP1) (“Megaport”), the world’s leading Network as a Service (NaaS) provider, today announced the acquisition of Extreme IX,India’s leading Internet Exchange operator, from Extreme Labs, a Bulgaria-headquartered software and network engineering company that incubated the Extreme IX platform. The acquisition expands Megaport’s global platform into one of the world’s fastest-growing digital infrastructure markets and supports the Company’s strategy to deliver scalable, high-performance connectivity services across APAC. The acquisition establishes Megaport’s presence across seven Internet Exchanges in major Indian metros: Delhi, Kolkata, Hyderabad, Chennai, Bengaluru, Mumbai, and Pune, connecting 40+ data centres and more than 400 customers. It also accelerates Megaport’s planned market entry by nearly thr

IonQ and QuantumBasel Expand Long-Term Partnership in Next-Generation Quantum Systems17.12.2025 22:10:00 CET | Press release

Extension solidifies QuantumBasel as IonQ’s Innovation Center in Europe; adds IonQ Tempo and next-generation system to advance quantum commercialization IonQ (NYSE: IONQ), the world’s leading quantum company, today announced an expanded agreement with QuantumBasel, the quantum initiative of uptownBasel, Switzerland’s innovation campus. The extended contract grants QuantumBasel ownership of its existing IonQ Forte Enterprise system and secures ownership of a next-generation Tempo system. This new agreement brings the total deal value of the QuantumBasel and IonQ partnership to over $60 million and extends IonQ’s on-site presence in Switzerland four more years, continuing through 2029. QuantumBasel is IonQ’s official Innovation Center in Europe, serving as a hub for European industry, academia, and research institutions to explore practical quantum computing applications and access IonQ’s latest enterprise-grade systems. “Our extended partnership with QuantumBasel represents a cornerston

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye